Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological therapeutics, today announced the Aseptic Process Simulation (APS) qualification of its sterile manufacturing facility and newly available fill/finish capacity.
Oral health strategies for healthy aging: A call to action
Research explores the connection between aging populations and oral health, proposing an integrated model to address health challenges in older adults, with a focus on